|
Market Closed -
Nasdaq
01:00:00 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 29.58 USD | -6.07% |
|
-7.45% | -16.72% |
Company Valuation: Cogent Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 341.9 | 808 | 506.4 | 862.2 | 5,404 | 5,134 | - | - |
| Change | - | 136.3% | -37.32% | 70.26% | 526.72% | -4.99% | - | - |
| Enterprise Value (EV) 1 | 341.9 | 808 | 506.4 | 862.2 | 4,742 | 5,005 | 4,976 | 4,808 |
| Change | - | 136.3% | -37.32% | 70.26% | 449.94% | 5.54% | -0.57% | -3.38% |
| P/E | -4.59x | -4.84x | -2.43x | -4.02x | -16.4x | -13.3x | -26.5x | 38.9x |
| PBR | - | - | 1.81x | 3.36x | 8.99x | 13.1x | 12.9x | 9.93x |
| PEG | - | -0.2x | -1.94x | 0.2x | -1.4x | -4.01x | 0.5x | -0x |
| Capitalization / Revenue | - | - | - | - | - | 857x | 18.1x | 6.74x |
| EV / Revenue | - | - | - | - | - | 836x | 17.5x | 6.31x |
| EV / EBITDA | - | - | -2.46x | -3.15x | -14.3x | -12.2x | -17.8x | 145x |
| EV / EBIT | -4.53x | -5.47x | -2.43x | -3.12x | -14.2x | -12.1x | -21.2x | 32.3x |
| EV / FCF | - | - | -3.24x | -4.14x | -17.8x | -15.7x | -33.7x | 38.1x |
| FCF Yield | - | - | -30.9% | -24.2% | -5.61% | -6.36% | -2.96% | 2.62% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.87 | -2.39 | -2.42 | -1.94 | -2.16 | -2.232 | -1.114 | 0.7613 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 5.989 | 283.7 | 761.4 |
| EBITDA 1 | - | - | -205.9 | -273.5 | -330.8 | -409 | -280.2 | 33.24 |
| EBIT 1 | -75.55 | -147.8 | -208.1 | -275.9 | -333.4 | -412.8 | -234.9 | 148.9 |
| Net income 1 | -72.27 | -140.2 | -192.4 | -255.9 | -328.9 | -395.3 | -216.9 | 145.1 |
| Net Debt 1 | - | - | - | - | -662 | -129.6 | -158.1 | -326.4 |
| Reference price 2 | 8.58 | 11.56 | 5.88 | 7.80 | 35.52 | 29.58 | 29.58 | 29.58 |
| Nbr of stocks (in thousands) | 39,851 | 69,893 | 86,124 | 110,539 | 152,128 | 173,569 | - | - |
| Announcement Date | 15/03/22 | 14/03/23 | 26/02/24 | 25/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.25x | 835.67x | -12.24x | -.--% | 5.13B | |
| 18.32x | 6.97x | 13.35x | 1.63% | 69.4B | |
| 30.72x | 8.25x | 27.72x | 0.05% | 57.24B | |
| 39.18x | 6.93x | 20.69x | 0.83% | 57.62B | |
| 34.57x | 3.29x | 14.19x | -.--% | 43.65B | |
| 51.08x | 5.91x | 32.37x | -.--% | 44.03B | |
| -18.44x | 177.78x | -19.56x | -.--% | 38.08B | |
| 36.57x | 9x | 23.45x | 0.36% | 36.31B | |
| 44.16x | 7.87x | 26.34x | -.--% | 32.61B | |
| 29.41x | 6.22x | 16.14x | -.--% | 25.47B | |
| Average | 25.23x | 106.79x | 14.24x | 0.29% | 40.95B | |
| Weighted average by Cap. | 28.79x | 33.11x | 17.25x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- COGT Stock
- Valuation Cogent Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
